Introduction
============

Lipid rafts are small heterogeneous cholesterol and sphingolipid-enriched membrane domains involved in various biological processes \[[@b1]\]. Partition of molecules in plasma membrane lipid rafts favours their internalization *via* a process called raft-dependent endocytosis, generally characterized as clathrin-independent and sensitive to cholesterol depletion \[[@b2]--[@b4]\]. However, substantial heterogeneity in the regulation of raft-dependent endocytic pathways exists, in particular with respect to their dynamin dependence and the role of caveolae and the caveolar coat protein, caveolin-1 (Cav1) \[[@b4]\].

Dynamin-dependent caveolae-mediated endocytosis has been implicated in the internalization of simian virus 40 (SV40), lactosylceramide, albumin and GM1-ganglioside binding cholera toxin--B sub-unit (CT-b) \[[@b5]--[@b13]\]. However, more recent studies have proposed that CT-b is internalized from the cell surface predominantly *via* clathrin-dependent endocytosis and dynamin-independent raft endocytosis \[[@b14]--[@b16]\]. In Cav1^−/--^ mouse embryo fibroblasts (MEFs), CT-b and SV40 are internalized *via* a dynamin independent, non-caveolar raft pathway that invokes tubular carriers \[[@b15], [@b17]\]. In wild-type MEFs, 50% of CT-b was internalized *via* clathrin-dependent endocytosis and essentially the rest by a dynamin-independent, non-caveolar pathway \[[@b15]\] that may involve flotillin-defined raft domains \[[@b16]\]. Interestingly, dynamin-regulated delivery of CT-b from the tubular carriers to the Golgi and not internalization at the cell surface questioning the extent to which CT-b is internalized *via* caveolar and dynamin-dependent raft endocytic pathways \[[@b15]\].

Cav1 over-expression prevents internalization of raft-dependent ligands such as CT-b, albumin, dysferlin and autocrine motility factor \[[@b15], [@b18]--[@b22]\]. Cav1 expression may negatively regulate raft-dependent endocytosis by sequestering ligands and their receptors in stable cell surface caveolae \[[@b3], [@b15], [@b20]\]. However, we recently demonstrated that Cav1 expression below the threshold required for caveolae formation can suppress EGFR signalling and cell surface diffusion of both EGFR and CT-b describing a regulatory function for Cav1 independently of caveolae \[[@b23]\]. Mammary epithelial tumour cells derived from wild-type PyMT transgenic mice express high levels of Cav1 and caveolae, whereas tumour cells from mice deficient for Golgi N-acetylglucosaminyltransferase V (Mgat5^−/--^) express Cav1 at levels below the threshold for caveolae formation. PyMT Mgat5^−/--^ tumours generally grow more slowly, but a minority 'escape' the Mgat5 null phenotype (Mgat5^−/--ESC^) and show rapid growth and loss of Cav1 expression \[[@b23], [@b24]\]. In this cell model, oligomerized Cav1 microdomains, independently of caveolae formation, were found to be sufficient to impose growth restrictions on cells deficient for Mgat5 \[[@b23]\]. Here, using these cell lines, we show that Cav1 regulates the dynamin-dependent, raft-mediated internalization of CT-b under conditions where it is not associated with caveolae formation.

Materials and methods
=====================

Cell culture
------------

Mgat5^+/+^(2.6 and 2.8), Mgat5^−/--^ and Mgat5^−/--ESC^ cells were from PyMT tumours as previously described \[[@b23]--[@b25]\]. Rescue and ESC-rescue cells were obtained by infection of Mgat5^−/--^ and Mgat5^−/--ESC^ cells with the pMX-PIE retrovirus encoding for murine Mgat5 and placed under puromycin selection \[[@b23], [@b25]\]. Cells were grown in DMEM containing non-essential amino acids, [l]{.smallcaps}-glutamine, penicillin--streptomycin, vitamins (Invitrogen, Carlsbad, CA, USA) and 10% foetal bovine serum (Medicorp, Montreal, QC, Canada) at 37°C in a humidified 5% CO~2~/95% air incubator. Adenoviruses expressing either the tetracycline-regulated chimeric transcription activator (tTA) or HA-tagged wild-type dynamin-1, HA-tagged dynK44A mutant and myc-tagged caveolin-1 under the control of the tetracycline-regulated promoter were as previously described \[[@b20]\]. Transfection with specific mouse caveolin-1 siRNA or control siRNA oligonucleotides (Dharmacon, Lafayette, CO, USA) or with Cav1-wt, Cav1Y14F and Cav1F92A/V94A plasmids was as previously described \[[@b23]\].

Cholera toxin--B sub-unit endocytosis
-------------------------------------

Five μg/ml CT-b-FITC was incubated with cells for 15 or 30 min. at 37°C, rinsed with medium, fixed with 3% paraformaldehyde in PBS, extensively rinsed with PBS and labelled with mouse mAb against Golgi GM130 (Transduction Laboratories, San Jose, CA, USA), polyclonal anti-Cav1 that recognizes both Cav1 and Cav2 (Santa Cruz sc-984, Santa Cruz, CA, USA) and species-specific Alexa568- and Alexa647-conjugated secondary antibodies (Molecular Probes, Invitrogen). Where indicated, cells were treated for 30 min. at 37°C with 5 mM mβCD before incubation with CT-b-FITC in the presence of mβCD. To label cell surface GM1, cells were incubated at 4°C with 5 μg/ml CT-b-FITC, fixed with paraformaldehyde and labelled with polyclonal anti-Cav1 antibody and Alexa568-conjugated secondary antibodies. Images were acquired with 488 (for FITC), 568 and 633 nm laser lines and 60χ Planapochromat objective using the Hi-Lo lookup table of an Olympus FV1000 (Olympus, Markham, ON, Canada) confocal microscope. CT-b-FITC endocytosis to the Golgi apparatus was quantified from at least 20 cells from six individual confocal images by determining the proportion of cellular CT-b-FITC labelling that overlapped with the GM130-labelled Golgi using the M1 function in Image Pro Plus software (Mediacybernetics, Bethesda, MD, USA). Cell surface GM1 and Cav1/2 expression were quantified by measuring the cell-associated fluorescence intensity of the respective channels of images acquired with equivalent acquisition settings using Image Pro Plus software. Data are presented as mean ± S.E. of at least three separate experiments.

Flow cytometry
--------------

Mgat5^−/--ESC^ cells were treated with mβCD or infected with adenoviruses encoding for clathrin-hub, dynamin-wt, dynamin K44A and Cav1 \[[@b20]\]. After 48 hrs, cells were incubated for 30 min. at 37°C with either 1 μg/ml CT-b-FITC or 15 μg/ml Tf-FITC. To remove surface-bound fluorescent ligand, cells were rapidly chilled on ice and washed with ice-cold acidic buffer (0.5 mM NaCl, 0.2 mM acetic acid, pH 2) \[[@b26]\]. For flow cytometry, at least 50,000 cells were acquired and analyzed using FACSCalibur and Cellquest software (BD Biosciences, San Jose, CA, USA). Data are the means ± S.E. of triplicates and are representative of three separate experiments.

Results
=======

Reduced Cav1 increases dynamin-dependent, raft-mediated endocytosis of CT-b to the Golgi
----------------------------------------------------------------------------------------

As previously reported \[[@b23]\], quantitative immunofluorescence shows that Mgat5^−/--^ cells show approximately 50% reduction in Cav1 levels, below the threshold for caveolae formation, compared with Mgat5^+/+^ cells, whereas Mgat5^−/--ESC^ cells display significantly reduced Cav1 expression compared with both cell lines ([Fig. 1A](#fig01){ref-type="fig"}). Rescue of Mgat5^−/--^ cells (Rescue) with an Mgat5 expressing retrovirus restored Cav1 expression to levels observed in Mgat5^+/+^ cells. However, upon rescue, Mgat5^−/--ESC^ cells (ESC-Rescue) still showed reduced Cav1 levels ([Fig. 1A](#fig01){ref-type="fig"}). GM1 expression impacts on CT-b uptake \[[@b27]\] and we verified that all cell lines displayed similar surface GM1 levels by labelling with CT-b-FITC at 4°C ([Fig. 1A](#fig01){ref-type="fig"}). However, following addition of CT-b at 37°C, only Mgat5^−/--ESC^ and ESC-Rescue cells, which express reduced Cav1 levels, showed increased CT-b endocytosis to the Golgi ([Fig. 1B](#fig01){ref-type="fig"}). These results are consistent with our previous demonstration that loss of Cav1 in Mgat5^−/--ESC^ cells was associated with increased cell surface diffusion of CT-b \[[@b23]\]. The fact that ESC-Rescue cells displayed the same elevated CT-b uptake as Mgat5^−/--ESC^ cells indicates that Mgat5 expression does not impact on CT-b internalization ([Fig. 1B](#fig01){ref-type="fig"}).

![Reduced caveolin expression in Mgat5^−/--ESC^ and ESC-Rescue cells is associated with increased CT-b uptake to the Golgi. (A) Mgat5^+/+^ (2.6 and 2.8), Mgat5^−/--^, Rescue, Mgat5^−/--ESC^ and ESC-Rescue cells were probed for cell surface expression of GM1 with CT-b at 4°C (top) or labelled with polyclonal anti-Cav1 antibody that recognizes both Cav1 and Cav2 (Cav1/2) (bottom). Fluorescent intensity of cell-associated CT-b-FITC and total anti-Cav1/2 immunolabelling was quantified. (B) Mgat5^+/+^ (2.6 and 2.8), Mgat5^−/--^, Rescue, Mgat5^−/--ESC^ and ESC-Rescue cells were incubated with CT-b-FITC for 15 and 30 min. at 37°C, and the cells were then fixed and labelled for the Golgi marker GM130 and CT-b delivery to the Golgi quantified. Merged images are presented for CT-b-FITC endocytosis at 30 min. (green) and the GM130 labelled Golgi (red). CT-b-FITC co-localization with the Golgi apparatus at 15 and 30 min. incubation was quantified. Bars = 20 μm. \**P* \< 0.01 relative to Mgat5^+/+^ (2.6) cells.](jcmm0013-3218-f1){#fig01}

Internalization of CT-b to the Golgi in Mgat5^−/--ESC^ cells was sensitive to cholesterol depletion with methyl-β-cyclodextrin (mβCD), inhibited by adenoviral expression of the dynamin K44A mutant but not wild-type dynamin and not affected by over-expression of the clathrin-hub ([Fig. 2A](#fig02){ref-type="fig"}). CT-b is therefore delivered to the Golgi apparatus of Mgat5^−/--ESC^ cells *via* a clathrin-independent, dynamin-dependent raft pathway. Over-expression of Cav1 has previously been shown to inhibit CT-b internalization \[[@b15], [@b19]\]. Consistent with these results, CT-b internalization to the Golgi was greatly reduced in Mgat5^−/--ESC^ cells infected with Cav1-expressing adenovirus ([Fig. 2A](#fig02){ref-type="fig"}).

![Cav1 regulation of CT-b endocytosis requires an intact scaffolding domain but not phosphorylation on tyrosine 14. (A) Mgat5^−/--ESC^ cells were treated with mβCD for 30 min. or infected with adenoviruses encoding for clathrin-hub, dynamin-wt, dynamin K44A or Cav1 and then incubated with CT-b-FITC (green) for 30 min. at 37°C. Cells were then fixed and labelled with GM130 (red). Co-localization of CT-b and Golgi was quantified for the indicated experimental conditions. (B) Mgat5^−/--ESC^ cells were transfected with Cav1-wt or Cav1 Y14F and F92A/V94A mutants and processed for endocytosis. Cells were then fixed and labelled with anti-GM130 and anti-myc antibodies to identify transfected cells and CT-b-FITC/Golgi co-localization was quantified. \**P* \< 0.01 relative to control cells.](jcmm0013-3218-f2){#fig02}

Cav1-negative regulation of raft-dependent endocytosis is caveolae-independent and scaffolding domain-dependent
---------------------------------------------------------------------------------------------------------------

Cav1 contains a scaffolding domain implicated in Cav1 oligomerization and receptor sequestration as well as a Src-kinase tyrosine phosphorylation site (Y14) that is associated with EGF-induced caveolae formation and focal adhesion turnover \[[@b28]--[@b31]\]. The ability of Cav1 to interact with EGFR and restrict the EGF signalling response was found to be dependent on the scaffolding domain and not Cav1 tyrosine phosphorylation \[[@b23]\]. Mgat5^−/--ESC^ cells transfected with Cav1 mutant in the Y14 tyrosine phosphorylation site (Cav1Y14F) mutant displayed a similar reduction in CT-b internalization to the Golgi as cells expressing wild-type Cav1 ([Fig. 2B](#fig02){ref-type="fig"}). However, the Cav1F92A/V94A scaffolding domain mutant was unable to significantly reduce CT-b internalization in Mgat5^−/--ESC^ cells ([Fig. 2B](#fig02){ref-type="fig"}). These data indicate that the Cav1 scaffolding domain, but not its tyrosine phosphorylation, is critical for Cav1-negative regulation of CT-b endocytosis.

Conversely, siRNA-mediated knock-down of Cav1 in Mgat5^+/+^ and Mgat5^−/--^ cells, resulting in decreased Cav1 expression, significantly increased uptake of CT-b to the Golgi ([Fig. 3A](#fig03){ref-type="fig"} and B). Uptake of CT-b in Mgat5^−/--^ cells following Cav1 siRNA treatment was dynamin- and cholesterol-dependent and clathrin-independent ([Fig. 3C](#fig03){ref-type="fig"}) showing that Cav1 is negatively regulating the raft-dependent endocytosis of CT-b. The fact that reduction of Cav1 levels in Mgat5^−/--^ cells, lacking caveolae \[[@b23]\], increases CT-b uptake demonstrates that Cav1 regulates raft-dependent endocytosis independently of caveolae.

![Cav1 siRNA knock-down increases raft-dependent endocytosis of CT-b-FITC to the Golgi. (A) Mgat5^−/--^ cells were treated with non-specific or Cav1 siRNA and incubated with CT-b-FITC for 30 min. prior to fixation and labelling for Cav1 and GM130. Individual images of CT-b-FITC, GM130 and Cav1 as well as a merged image of CT-b and GM130 are presented. (B) Quantification of Cav1/2 expression (top) and CT-b uptake to the Golgi (bottom) following treatment of Mgat5^+/+^ and Mgat5^−/--^ with Cav1 siRNA is presented in graphic form and compared with the levels of Mgat5^−/--ESC^ cells. (C) Mgat5^−/--^ cells were treated with Cav1 siRNA and either treated with mβCD for 30 min. or infected with adenoviruses encoding for dynamin K44A or Cav1 prior to incubation with CT-b-FITC for 30 min., fixation and labelling for GM130 and quantification of CT-b uptake to the Golgi. Bars = 20 μm. \**P* \< 0.01, \*\**P* \< 0.05 relative to control cells.](jcmm0013-3218-f3){#fig03}

Cav1 regulation of CT-b endocytosis occurs indirectly at the cell surface
-------------------------------------------------------------------------

CT-b has been shown to follow a two-step path to the Golgi apparatus *via* caveosomes with dynamin blocking CT-b delivery to the Golgi at an intracellular site \[[@b11], [@b15]\]. We therefore established whether inhibition of CT-b endocytosis by dynamin and Cav1 occurs at the cell surface or intracellularly. After incubation with CT-b-FITC at 37°C, cells were acid washed to eliminate any cell surface label and intracellular CT-b-FITC measured by flow cytometry. CT-b-FITC labelling at 4°C provided a control for efficacy of cell surface removal of CT-b-FITC by acid washing and use of the same conditions on clathrin-dependent transferrin (Tf) uptake showed specificity for raft-dependent endocytosis ([Fig. 4](#fig04){ref-type="fig"}). mβCD treatment and over-expression of Cav1 and dynamin K44A completely inhibited cellular uptake of CT-b to levels observed at 4°C. Conversely, infection with the clathrin hub adenovirus did not impact on intracellular accumulation of CT-b-FITC but did block Tf-FITC uptake ([Fig. 4B](#fig04){ref-type="fig"}).

![Cav1 and dynamin regulate raft-dependent CT-b endocytosis at the cell surface. (A) Mgat5^−/--ESC^ cells were not treated (Control), treated with mβCD or infected with adenoviruses encoding for clathrin-hub, dynamin K44A and Cav1 and incubated with CT-b-FITC at 37°C for 30 min. and cell surface CT-b removed by acid washing. Alternatively, cells were not incubated with CT-b (Untreated), not acid-washed (wo A.W.) or incubated with CT-b-FITC at 4°C. Prior to flow cytometry, cells were incubated with propidium iodide (PI) to identify dead cells. Representative flow cytometry profiles are shown for PI and CT-b-FITC intensities under the various conditions, as indicated. (B) Percent positive cells was determined following incubation with CT-b-FITC (left) or Tf-FITC (right) for the conditions indicated earlier. Cells were acid washed in order to remove surface-bound CT-b-FITC or Tf-FITC (black bars) except where indicated (wo A.W., white bars).](jcmm0013-3218-f4){#fig04}

No significant colocalization was observed between Cav1 and CT-b either in caveolae-expressing Mgat5^+/+^ cells or in Mgat5^−/--^ cells expressing oligomerized Cav1 microdomains but not caveolae ([Fig. 5](#fig05){ref-type="fig"}). Although some co-localization between CT-b and Cav1 could be observed in Mgat5^−/--ESC^ cell transfected with Cav1-mRFP, the fact that the inhibition of CT-b endocytosis by Cav1 over-expression was not associated with recruitment of CT-b to cell surface Cav1 domains is indicative of an indirect effect of Cav1 on CT-b endocytosis ([Fig. 5](#fig05){ref-type="fig"}).

![Minimal co-localization of cell surface CT-b and Cav1. Mgat5^+/+^ and Mgat5^−/--^ cells were incubated with CT-b-FITC (green) for 30 min. at 37°C, fixed and labelled for Cav1 (red). Alternatively, Mgat5^−/--ESC^ cells transfected with Cav1-mRFP (red) were incubated with CT-b-FITC (green) for 30 min. at 37°C (bottom row). Regions boxed in red are enlarged to reveal the incidence of co-localization. Bar = 20 μm.](jcmm0013-3218-f5){#fig05}

Discussion
==========

In the mammary epithelial tumour cells used here, CT-b is shown to be internalized predominantly *via* a cholesterol- and caveolin-1-sensitive, dynamin-dependent raft pathway. Inhibition of CT-b endocytosis by mβCD, the dynamin K44A mutant and Cav1 was shown to occur at the plasma membrane. This suggests that CT-b internalization in these cells follows an endocytic route different from the dynamin-independent pathway involving tubular intermediates reported in MEFs \[[@b15]\]. This study therefore further highlights the varied routes of endocytosis followed by CT-b in different cell types (reviewed in \[[@b4]\]). The basis for the choice of major endocytic route followed by CT-b in different cells remains uncertain. The internalization of CT-b *via* caveolae \[[@b10], [@b12]--[@b14], [@b32]\], the fact that Cav1^−/--^ MEFs show a switch in CT-b uptake from the clathrin pathway to a dynamin-independent raft pathway \[[@b15]\] and the ability of Cav1 expression to regulate the dynamin-dependent raft uptake of CT-b shown in this study argues that expression of Cav1 is one, but certainly not the only, determinant of the endocytic route followed by CT-b.

The ability of siRNA-mediated reduction of Cav1 levels in Mgat5^−/--^ cells, that express few or no caveolae \[[@b4]\], to increase CT-b delivery to the Golgi indicates that Cav1 regulation of endocytosis is independent of caveolae formation. Although Mgat5^−/--^ cells express Cav1 at levels below the threshold for caveolae formation, they still express oligomeric Cav1 that recruits EGFR and functionally regulates cell surface CT-b and EGFR diffusion \[[@b23]\]. Indeed, the scaffolding domain of Cav1 was crucial for Cav1-negative regulation of CT-b endocytosis as a scaffolding domain mutant, but not mutation of the Y14 tyrosine phosphorylation site, inhibited CT-b uptake to the Golgi apparatus. Similarly, mutation of the Cav1 scaffolding domain, but not the Y14 tyrosine phosphorylation site, inhibited EGFR signalling \[[@b4]\]. However, minimal CT-b co-localization with Cav1 contrasts the recruitment of EGFR to Cav1 microdomains previously observed in the Mgat5^−/--^ cells \[[@b23]\]. Similarly, negative regulation by caveolin of dysferlin endocytosis requires the scaffolding domain but not dysferlin association with caveolins or caveolae \[[@b22]\]. The Cav1 scaffolding domain mediates interaction with various receptors, the formation of Cav1 oligomers and Cav1 interaction with cholesterol \[[@b29]\]. The ability of reduced levels of Cav1 to regulate raft-dependent CT-b internalization together with its minimal co-localization with uninternalized cell surface CT-b leads us to believe that expression of Cav1 and of oligomerized Cav1 microdomains impact at distance on raft functionality.

Cav1 interacts with dynamin-2 \[[@b33]\] and Cav1 could potentially regulate raft endocytosis by sequestering dynamin-2 away from rafts. Although such sequestration of dynamin-2 should also affect clathrin-dependent uptake, Cav1 does not affect Tf uptake ([Fig. 4](#fig04){ref-type="fig"}). Alternatively, Cav1 may function as a store of lipid raft components such as cholesterol or sphingolipids that may be released under specific conditions \[[@b34]\]. Indeed, cholesterol and glycosphingolipids can over-ride Cav1-dependent negative regulation of the caveolar uptake of lactosyl ceramide \[[@b21]\] and plasma membrane sphingomyelin is required for CT entry into cells \[[@b35]\]. Cav1 is a cholesterol-binding protein \[[@b36]\] and its sequestration of cholesterol may impact on the functionality, including the endocytic potential, of non-caveolar raft domains. Indeed, whether raft domains are small, transient and dynamic or exist as a continuum \[[@b37], [@b38]\], stable Cav1 expressing microdomains with the capacity to interact with and sequester raft components will necessarily impact on their composition, functionality and endocytic potential. Indirect regulation of raft-dependent endocytosis by oligomerized Cav1 microdomains, or scaffolds, therefore represents a regulatory mechanism distinct from sequestration of endocytic ligand by invaginated caveolae. This provides a novel functional role for oligomerized Cav1 microdomains outside caveolae.
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